Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body. Scientists at the Technical University of Munich (TUM) have succeeded in explaining the molecular fundamentals of these additional effects. The results also shine a new light on other known molecular processes which could indicate an approach to the treatment of inflammatory illnesses.
The fact that a given medication has been approved for use doesn't automatically mean that all of its mechanisms of action have been completely investigated and understood. New findings and technical possibilities continuously enable more precise insights into the processes that take place within the human body. As a result, we constantly gain a better understanding of how known medicines work and what approaches could be practical for new medications.
PD Dr. Olaf Groß, group leader at the TUM Institute for Clinical Chemistry and Pathobiochemistry , has been working together with his team to investigate Imiquimod. This medication has been successfully used to treat viral skin infections and certain types of skin cancer since 1997. The scientists have now published their results in the journal "Immunity".
Imiquimod is an immunomodulatory agent, which means it triggers an immune reaction which causes the body's immune system to attack modified cells. For several years, this process was the medication's only known mechanism of action. However, in the meantime it has been shown that imiquimod also triggers other processes in the body. On one hand, imiquimod directly impairs the growth of cancer cells.
On the other hand, Imiquimod activates a complex within cells of the immune system termed the inflammasome. While the inflammasome is very important for our body’s ability to defend against infection, uncontrolled activation of the inflammasome can lead to inflammatory diseases. "We think that these other mechanisms of action of Imiquimod might contribute to the efficacy or adverse side effects of the medication," says Olaf Groß.
Intervention in the mitochondria
Imiquimod specifically activates the NLRP3 inflammasome, which is a special type of inflammasome that responds to tissue stress and cellular damage. Olaf Groß and his team were able to show that NLRP3 is activated because Imiquimod impairs the respiratory chain in mitochondria. The respiratory chain is a series of mitochondrial protein complexes that generates the energy, in the form of a molecule called adenosine triphosphate, or ATP for short, that cells need to survive.
"Inhibition of the respiratory chain by imiquimod not only impairs ATP production, but also results in the production of toxic oxygen radicals," explains Dr. Ritu Mishra, one of the two primary authors of the study. "Imiquimod causes an especially large amount of radicals to be released. In contrast to other substances that intervene in the respiratory chain but generate a lower amount of radicals, here a threshold value is exceeded that results in the activation of NLRP3."
Implications for anti-inflammatory medications
"There is a lot of excitement about generating new anti-inflammatory medications by targeting the NLRP3 inflammasome," says Dr. Christina J. Groß, also one of the study's primary authors. "We hope that our research will lead to the design of medications that can prevent dangerous hyperactivation of the NLRP3 inflammasome that may occur in diseases like gout and multiple sclerosis." Olaf Groß and his team are following-up on this study by investigating whether the effect of imiquimod on the mitochondria is the mechanism behind the unexplained finding that imiquimod directly inhibits growth of cancer cells. After that, they plan to investigate new chemical substances related to Imiquimod in order to find out how the various effects of the medication can be uncoupled.
C.J. Groß, R. Mishra, K.S. Schneider, G. Médard, J. Wettmarshausen, D.C. Dittlein, H. Shi, O. Gorka, P.-A. Koenig, S. Fromm, G. Magnani, T. Ćiković, L. Hartjes, J. Smollich, A.A.B. Robertson, M.A. Cooper, M. Schmidt-Supprian, M. Schuster, K. Schroder, P. Broz, C. Traidl-Hoffmann, B. Beutler, B. Kuster, J. Ruland, S. Schneider, F. Perocchi, O. Groß. "K+ Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria". Immunity (2016). DOI: http://dx.doi.org/10.1016/j.immuni.2016.08.010
PD Dr. rer. nat. Olaf Groß
Institute for Clinical Chemistry and Pathobiochemistry
Klinikum rechts der Isar
Technical University of Munich
+49 89 4140-4874
Dr. Ulrich Marsch | Technische Universität München
Could this protein protect people against coronary artery disease?
17.11.2017 | University of North Carolina Health Care
Microbial resident enables beetles to feed on a leafy diet
17.11.2017 | Max-Planck-Institut für chemische Ökologie
The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.
Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...
Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.
That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...
Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.
During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....
The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.
Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...
Pillared graphene would transfer heat better if the theoretical material had a few asymmetric junctions that caused wrinkles, according to Rice University...
15.11.2017 | Event News
15.11.2017 | Event News
30.10.2017 | Event News
17.11.2017 | Physics and Astronomy
17.11.2017 | Health and Medicine
17.11.2017 | Studies and Analyses